BCL2 and colorectal carcinoma: Activated STAT3 has been shown to be increased in CRC patients [43]; its activation induces certain anti-apoptotic agents, such as Bcl-2 and Bcl-xl, which in turn increase CRC cell survival, proliferation, incursion, and lymph node metastasis [44].